{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:21Z","timestamp":1762867101848,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"DOD-US\/MOD-Israel Project","award":["DT-PA-IS-0002"],"award-info":[{"award-number":["DT-PA-IS-0002"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.03.033","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T04:47:58Z","timestamp":1490244478000},"page":"6030-6040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes"],"prefix":"10.1016","volume":"35","author":[{"given":"Theodor","family":"Chitlaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma'ayan","family":"Israeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahar","family":"Rotem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erez","family":"Bar-Haim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avigdor","family":"Shafferman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.033_b0005","first-page":"1","article-title":"The impact of anthrax attacks on the American public","volume":"4","author":"Blendon","year":"2002","journal-title":"MedGenMed"},{"key":"10.1016\/j.vaccine.2017.03.033_b0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-065X.2010.00969.x","article-title":"Progress and novel strategies in vaccine development and treatment of anthrax","volume":"239","author":"Chitlaru","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2017.03.033_b0015","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/JCM.39.12.4566-4567.2001","article-title":"Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan","volume":"39","author":"Keim","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/jama.1997.03550050080037","article-title":"Iraq's biological weapons. The past as future?","volume":"278","author":"Zilinskas","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.03.033_b0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mam.2009.07.004","article-title":"Bacillus anthracis physiology and genetics","volume":"30","author":"Koehler","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.vaccine.2017.03.033_b0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2014.02.012","article-title":"Anthrax lethal and edema toxins in anthrax pathogenesis","volume":"22","author":"Liu","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0035","first-page":"59","article-title":"Chamberland, Roux. Summary report of the experiments conducted at Pouilly-le-Fort, near Melun, on the anthrax vaccination, 1881","volume":"75","author":"Pasteur","year":"2002","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.vaccine.2017.03.033_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(84)90003-3","article-title":"Anthrax: the disease in relation to vaccines","volume":"2","author":"Hambleton","year":"1984","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","article-title":"Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity","volume":"13","author":"Klimpel","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2009.06.003","article-title":"Membrane translocation by anthrax toxin","volume":"30","author":"Collier","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.vaccine.2017.03.033_b0055","series-title":"Anthrax","first-page":"61","article-title":"Structure and Function of Anthrax Toxin","author":"Lacy","year":"2002"},{"key":"10.1016\/j.vaccine.2017.03.033_b0060","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.03.033_b0065","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1128\/IAI.00244-12","article-title":"Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models","volume":"80","author":"Levy","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.micpath.2011.10.002","article-title":"The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits","volume":"52","author":"Levy","year":"2012","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2017.03.033_b0075","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1128\/IAI.06340-11","article-title":"Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax","volume":"80","author":"Lovchik","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0080","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1128\/IAI.70.12.6817-6827.2002","article-title":"Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening","volume":"70","author":"Ariel","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0085","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1128\/IAI.71.8.4563-4579.2003","article-title":"Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens","volume":"71","author":"Ariel","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0090","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1128\/JB.188.10.3551-3571.2006","article-title":"Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross talk mechanisms modulate extracellular proteolytic activities","volume":"188","author":"Chitlaru","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0095","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2217\/fmb.09.73","article-title":"Proteomic studies of Bacillus anthracis","volume":"4","author":"Chitlaru","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/pmic.200300575","article-title":"Identification of chromosomally encoded membranal polypeptides of Bacillus anthracis by a proteomic analysis: prevalence of proteins containing S-layer homology domains","volume":"4","author":"Chitlaru","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2017.03.033_b0105","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/IAI.02029-06","article-title":"Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome","volume":"75","author":"Chitlaru","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0110","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1128\/IAI.00174-06","article-title":"Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen","volume":"74","author":"Gat","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0115","series-title":"The Challenge of Highly Pathogenic Microorganisms","first-page":"295","article-title":"Reverse vaccinology in Bacillus anthracis Bacillus anthracis","author":"Shafferman","year":"2010"},{"key":"10.1016\/j.vaccine.2017.03.033_b0120","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1128\/AEM.00766-09","article-title":"Novel and unique diagnostic biomarkers for Bacillus anthracis infection","volume":"75","author":"Sela-Abramovich","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0125","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1038\/srep18908","article-title":"Next-generation bacillus anthracis live attenuated spore vaccine based on the htrA(-) (high temperature requirement A) sterne strain","volume":"6","author":"Chitlaru","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.03.033_b0130","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1365-2958.2011.07790.x","article-title":"HtrA is a major virulence determinant of Bacillus anthracis","volume":"81","author":"Chitlaru","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0135","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mam.2009.08.006","article-title":"Anthrax vaccination strategies","volume":"30","author":"Cybulski","year":"2009","journal-title":"Mol Aspects Med"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2017.03.033_b0140","doi-asserted-by":"crossref","first-page":"D28","DOI":"10.1016\/j.vaccine.2009.08.102","article-title":"Advances in the development of next-generation anthrax vaccines","volume":"27","author":"Friedlander","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0145","series-title":"Anthrax","first-page":"33","article-title":"Anthrax Vaccines","author":"Friedlander","year":"2002"},{"key":"10.1016\/j.vaccine.2017.03.033_b0150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fmicb.2015.01009","article-title":"Anthrax prophylaxis: recent advances and future directions","volume":"6","author":"Williamson","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/iai.52.2.509-512.1986","article-title":"Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig","volume":"52","author":"Little","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2013.10.039","article-title":"Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial","volume":"32","author":"Wright","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0165","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/IAI.68.8.4549-4558.2000","article-title":"Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax","volume":"68","author":"Cohen","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0170","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/iai.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fmicb.2015.00747","article-title":"Whole genome protein microarrays for serum profiling of immunodominant antigens of Bacillus anthracis","volume":"6","author":"Kempsell","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0180","doi-asserted-by":"crossref","first-page":"e57959","DOI":"10.1371\/journal.pone.0057959","article-title":"Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.033_b0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2958.2005.04848.x","article-title":"The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant","volume":"58","author":"Gat","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0190","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2958.2008.06460.x","article-title":"Characterization of Bacillus anthracis iron-regulated surface determinant (Isd) proteins containing NEAT domains","volume":"70","author":"Gat","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.micpath.2011.07.004","article-title":"Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits","volume":"51","author":"Levy","year":"2011","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2017.03.033_b0200","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1016\/j.vaccine.2004.11.077","article-title":"Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components","volume":"23","author":"Mendelson","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0205","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/IAI.74.3.1949-1953.2006","article-title":"Routine markerless gene replacement in Bacillus anthracis","volume":"74","author":"Janes","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0210","first-page":"211","article-title":"In vitro screen of bioinformatically selected Bacillus anthracis vaccine candidates by coupled transcription, translation, and immunoprecipitation analysis","volume":"375","author":"Gat","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/IAI.71.2.801-813.2003","article-title":"Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines","volume":"71","author":"Gat","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0220","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1128\/IAI.00792-06","article-title":"Protective antigen as a correlative marker for anthrax in animal models","volume":"74","author":"Kobiler","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1753425908100379","article-title":"Involvement of TLR2 in innate response to Bacillus anthracis infection","volume":"15","author":"Weiss","year":"2009","journal-title":"Innate Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0230","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/IAI.73.7.4043-4053.2005","article-title":"Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen","volume":"73","author":"Aloni-Grinstein","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8080243","article-title":"A simple luminescent adenylate-cyclase functional assay for evaluation of Bacillus anthracis edema factor activity","volume":"8","author":"Israeli","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.vaccine.2017.03.033_b0240","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/14760584.2015.981533","article-title":"Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design","volume":"14","author":"Altmann","year":"2015","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.03.033_b0245","first-page":"1506","article-title":"CD4+ T cells targeting dominant and cryptic epitopes from Bacillus anthracis lethal factor","volume":"6","author":"Ascough","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0250","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0255","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0260","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1586\/14760584.2013.814860","article-title":"Anthrax vaccines: present status and future prospects","volume":"12","author":"Kaur","year":"2013","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.03.033_b0265","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2013.12.026","article-title":"The delicate balance in genetically engineering live vaccines","volume":"32","author":"Galen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0270","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0264-410X(94)90223-2","article-title":"Human live anthrax vaccine in the former USSR","volume":"12","author":"Shlyakhov","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0275","series-title":"Bacterial toxins and virulence factors in disease New York","first-page":"543","article-title":"Anthrax toxins","author":"Leppla","year":"1995"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.03.033_b0280","doi-asserted-by":"crossref","first-page":"C36","DOI":"10.1016\/j.vaccine.2015.04.029","article-title":"Live attenuated vaccines for invasive Salmonella infections","volume":"33","author":"Tennant","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0285","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1016\/j.vaccine.2011.04.115","article-title":"Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection","volume":"29","author":"Barnoy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0290","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/172.3.883","article-title":"Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge","volume":"172","author":"Tacket","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.033_b0295","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2009.12.001","article-title":"Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization","volume":"28","author":"Conlan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.033_b0300","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/IAI.00530-08","article-title":"Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax","volume":"77","author":"Skoble","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.033_b0305","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/CVI.00099-13","article-title":"Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis","volume":"20","author":"Ionin","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.03.033_b0310","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrp.2012.07.006","article-title":"Serological correlate of protection in guinea pigs for a recombinant protective antigen anthrax vaccine produced from Bacillus brevis","volume":"3","author":"Chun","year":"2012","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.vaccine.2017.03.033_b0315","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2016.06.041","article-title":"Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing","volume":"34","author":"Stark","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:15Z","timestamp":1759400595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":63,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17303390"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}